1
|
Vezzani A, Friedman A and Dingledine RJ:
The role of inflammation in epileptogenesis. Neuropharmacology.
69:16–24. 2013. View Article : Google Scholar
|
2
|
Vezzani A and Rüegg S: The pivotal role of
immunity and inflammatory processes in epilepsy is increasingly
recognized: introduction. Epilepsia. 52(Suppl 3): 1–4.
2011.PubMed/NCBI
|
3
|
Fabene PF, Bramanti P and Constantin G:
The emerging role for chemokines in epilepsy. J Neuroimmunol.
224:22–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sharma A: Genome-wide expression analysis
in epilepsy: a synthetic review. Curr Top Med Chem. 12:1008–1032.
2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Foresti ML, Arisi GM, Katki K, Montañez A,
Sanchez RM and Shapiro LA: Chemokine CCL2 and its receptor CCR2 are
increased in the hippocampus following pilocarpine-induced status
epilepticus. J Neuroinflammation. 6:402009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Guzik-Kornacka A, Sliwa A, Plucinska G and
Lukasiuk K: Status epilepticus evokes prolonged increase in the
expression of CCL# and CCL4 mRNA and protein in the rat
brain. Acta Neurobiol Exp (Wars). 71:193–207. 2011.PubMed/NCBI
|
7
|
Fiala M, Avagyan H, Merino JJ, Bernas M,
Valdivia J, Espinosa-Jeffrey A, Witte M and Weinand M: Chemotactic
and mitogenic stimuli of neuronal apoptosis in patients with
medically intractable temporal lobe epilepsy. Pathophysiology.
20:59–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Louboutin JP, Chekmasova A, Marusich E,
Agrawal L and Strayer DS: Role of CCR5 and its ligands in the
control of vascular inflammation and leukocyte recruitment required
for acute excitotoxic seizure induction and neural damage. FASEB J.
25:737–753. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Marusich E, Louboutin JP, Chekmasova AA
and Strayer DS: Lymphocyte adhesion to CCR5 ligands is reduced by
anti-CCR5 gene delivery. J Neurol Sci. 308:25–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Liu JX, Cao X, Tang YC, Liu Y and Tang FR:
CCR7, CCR8, CCR9 and CCR10 in the mouse hippocampal CA1 area and
the dentate gyrus during and after pilocarpine-induced status
epilepticus. J Neurochem. 100:1072–1088. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Johnson EA, Dao TL, Guignet MA, Geddes CE,
Koemeter-Cox AI and Kan RK: Increased expression of the chemokines
CXL1 and MIP-1α by resident brain cells precedes neutrophil
infiltration in the brain following prolonged soman-induced status
epilepticus in rats. J Neuroinflammation. 8:412011.
|
12
|
Lee TS, Mane S, Eid T, Zhao H, Lin A, Guan
Z, Kim JH, Schweitzer J, King-Stevens D, Weber P, Spencer SS,
Spencer DD and de Lanerolle NC: Gene expression in temporal lobe
epilepsy is consistent with increased release of glutamate by
astrocytes. Mol Med. 13:1–13. 2007.PubMed/NCBI
|
13
|
Xu Y, Zeng K, Han Y, Wang L, Chen D, Xi Z,
Wang H, Wang X and Chen G: Altered expression of CX3CL1 in patients
with epilepsy and in a rat model. Am J Pathol. 180:1950–1962. 2012.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Yeo SI, Kim JE, Ryu HJ, Seo CH, Lee BC,
Choi IG, Kim DS and Kang TC: The roles of fractalkine/CX3CR1 system
in neuronal death following pilocarpine-induced status epilepticus.
J Neuroimmunol. 234:93–102. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kim JE, Ryu HJ, Yeo SI and Kang TC: P2X7
receptor regulates leukocyte infiltrations in rat frontoparietal
cortex following status epilepticus. J Neuroinflammation. 7:652010.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Manley NC, Bertrand AA, Kinney KS, Hing TC
and Sapolsky RM: Characterization of monocyte chemoattractant
protein-1 expression following a kainate model of status
epilepticus. Brain Res. 1182:138–143. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Sheehan JJ, Zhou C, Gravanis I, Rogove AD,
Wu YP, Bogenhagen DF and Tsirka SE: Proteolytic activation of
monocyte chemoattractant protein-1 by plasmin underlies excitotoxic
neurodegeneration in mice. J Neurosci. 27:1738–1745. 2007.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Wu Y, Wang X, Mo X, Xi Z, Xiao F, Li J,
Zhu X, Luan G, Wang Y, Li Y and Zhang J: Expression of monocyte
chemoattractant protein-1 in brain tissue of patients with
intractable epilepsy. Clin Neuropathol. 27:55–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Miller G: Neuroscience. The dark side of
glia. Science. 308:778–781. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Shapiro LA, Wang L and Ribak CE: Rapid
astrocyte and microglial activation following pilocarpine-induced
seizures in rats. Epilepsia. 49(Suppl 2): 33–41. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Rogove AD and Tsirka SE: Neurotoxic
responses by microglia elicited by excitotoxic injury in the mouse
hippocampus. Curr Biol. 8:19–25. 1998. View Article : Google Scholar : PubMed/NCBI
|
22
|
Abraham J, Fox PD, Condello C, Bartolini A
and Koh S: Minocycline attenuates microglia activation and blocks
the long-term epileptogenic effects of early-life seizures.
Neurobiol Dis. 46:425–430. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Nurmi A, Goldsteins G, Närväinen J,
Pihlaja R, Ahtoniemi T, Gröhn O and Koistinaho J: Antioxidant
pyrrolidine dithiocarbamate activates AKT-GSK signaling and is
neuroprotective in neonatal hypoxia-ischemia. Free Radic Biol Med.
40:1776–1784. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chuang YC, Chen SD, Lin TK, Chang WN, Lu
CH, Liou CW, Chan SH and Chang AY: Transcriptional upregulation of
nitric oxide synthase II by nuclear factor-kappaB promotes
apoptotic neuronal cell death in the hippocampus following
experimental status epilepticus. J Neurosci Res. 88:1898–1907.
2010.
|
25
|
Shin EJ, Jhoo JH, Kim WK, Jhoo WK, Lee C,
Jung BD and Kim HC: Protection against kainate neurotoxicity by
pyrrolidine dithiocarbamate. Clin Exp Pharmacol Physiol.
31:320–326. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Soerensen J, Pekcec A, Fuest C, Nickel A
and Potschka H: Pyrrolidine dithiocarbamate protects the piriform
cortex in the pilocarpine status epilepticus model. Epilepsy Res.
87:177–183. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Racine RJ: Modification of seizure
activity by electrical stimulation. II. Motor seizure.
Electroencephalogr Clin Neurophysiol. 32:281–294. 1972. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yu N, Di Q, Liu H, Hu Y, Jiang Y, Yan YK,
Zhang YF and Zhang YD: Nuclear factor-kappa B activity regulates
brain expression of P-glycoprotein in the kainic acid-induced
seizure rats. Mediators Inflamm. 2011:6706132011.PubMed/NCBI
|
29
|
Ryu HJ, Kim JE, Yeo SI, Kim MJ, Jo SM and
Kang TC: ReLA/P65-serine 536 nuclear factor-kappa B phosphorylation
is related to vulnerability to status epilepticus in the rat
hippocampus. Neuroscience. 187:93–102. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Wang L, Liu YH, Huang YG and Chen LW:
Time-course of neuronal death in the mouse pilocarpine model of
chronic epilepsy using Fluoro-Jade C staining. Brain Res.
1241:157–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
31
|
Lubin FD, Ren Y, Xu X and Anderson AE:
Nuclear factor-kappa B regulates seizure threshold and gene
transcription following convulsant stimulation. J Neurochem.
103:1381–1395. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Liu GJ, Huang JM, Li XB, Meng LQ and Huang
RY: Effect of pyrrolidine dithiocarbamate on expression of nuclear
factor-κB and related inflammatory factors in rat hippocampus after
epilepsy. Chin J Behav Med & Brain Sci. 20:784–786. 2011.(In
Chinese).
|
33
|
Banisadr G, Gosselin RD, Mechighel P,
Rostène W, Kitabgi P and Mélik Parsadaniantz S: Constitutive
neuronal expression of CCR2 chemokine receptor and its
colocalization with neurotransmitters in normal rat brain:
functional effect of MCP-1/CCL2 on calcium mobilization in primary
cultured neurons. J Comp Neurol. 492:178–192. 2005. View Article : Google Scholar
|
34
|
Donadelli R, Abbate M, Zanchi C, Corna D,
Tomasoni S, Benigni A, Remuzzi G and Zoja C: Protein traffic
activates NF-κB gene signaling and promotes MCP-1-dependent
interstitial inflammation. Am J Kidney Dis. 36:1226–1241. 2000.
|
35
|
Kim YS, Kim JS, Kwon JS, Jeong MH, Cho JG,
Park JC, Kang JC and Ahn Y: BAY 11–7082, a nuclear factor-κB
inhibitor, reduces inflammation and apoptosis in a rat cardiac
ischemia-reperfusion injury model. Int Heart J. 51:348–353.
2010.
|
36
|
Quan Y, Jiang CT, Xue B, Zhu SG and Wang
X: High glucose stimulates TNFα and MCP-1 expression in rat
microglia via ROS and NF-κB pathways. Acta Pharmacol Sin.
32:188–193. 2011.
|
37
|
Yadav A, Saini V and Arora S: MCP-1:
chemoattractant with a role beyond immunity: a review. Clin Chim
Acta. 411:1570–1579. 2010. View Article : Google Scholar : PubMed/NCBI
|
38
|
Streit WJ, Walter SA and Pennell NA:
Reactive microgliosis. Prog Neurobiol. 57:563–581. 1999. View Article : Google Scholar
|
39
|
Vezzani A, Conti M, De Luigi A, Ravizza T,
Moneta D, Marchesi F and De Simoni MG: Interleukin-1beta
immunoreactivity and microglia are enhanced in the rat hippocampus
by focal kainate application: functional evidence for enhancement
of electrographic seizures. J Neurosci. 19:5054–5065.
1999.PubMed/NCBI
|
40
|
Kim SY, Choi YS, Choi JS, Cha JH, Kim ON,
Lee SB, Chung JW, Chun MH and Lee MY: Osteopontin in kainic
acid-induced microglial reactions in the rat brain. Mol Cells.
13:429–435. 2002.PubMed/NCBI
|
41
|
Fu W, Lee J, Guo Z and Mattson MP:
Seizures and tissue injury induce telomerase in hippocampal
microglial cells. Exp Neurol. 178:294–300. 2002. View Article : Google Scholar : PubMed/NCBI
|
42
|
Ravizza T, Rizzi M, Perego C, Richichi C,
Velísková J, Moshé SL, De Simoni MG and Vezzani A: Inflammatory
response and glia activation in developing rat hippocampus after
status epilepticus. Epilepsia. 46(Suppl 5): 113–117. 2005.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Quan Y, Du J and Wang X: High glucose
stimulates gro secretion from rat microglia via ROS, PKC, and
NF-kappaB pathways. J Neurosci Res. 85:3150–3159. 2007. View Article : Google Scholar : PubMed/NCBI
|